SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $3,000 | -66.7% | 60 | -60.3% | 0.00% | -50.0% |
Q2 2021 | $9,000 | -35.7% | 151 | -17.0% | 0.00% | -33.3% |
Q1 2021 | $14,000 | -30.0% | 182 | -20.2% | 0.00% | -40.0% |
Q4 2020 | $20,000 | +5.3% | 228 | -28.3% | 0.01% | 0.0% |
Q3 2020 | $19,000 | +26.7% | 318 | +55.9% | 0.01% | +25.0% |
Q4 2019 | $15,000 | +650.0% | 204 | +1600.0% | 0.00% | +300.0% |
Q3 2019 | $2,000 | -90.5% | 12 | -89.6% | 0.00% | -88.9% |
Q2 2019 | $21,000 | – | 115 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |